Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest

Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental cell research 2001-11, Vol.270 (2), p.199-213
Hauptverfasser: Presland, Richard B., Kuechle, Melanie K., Lewis, S.Patrick, Fleckman, Philip, Dale, Beverly A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 213
container_issue 2
container_start_page 199
container_title Experimental cell research
container_volume 270
creator Presland, Richard B.
Kuechle, Melanie K.
Lewis, S.Patrick
Fleckman, Philip
Dale, Beverly A.
description Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.
doi_str_mv 10.1006/excr.2001.5348
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1006_excr_2001_5348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014482701953480</els_id><sourcerecordid>11640884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</originalsourceid><addsrcrecordid>eNp1kN1KwzAUx4MoOj9uvZQ8gJ1Jm6bZ5ZibEweC6HVJ05MZzdqRpLLd-QiCb-iTmDrBKyFwQv4fOfwQOqdkSAnhV7BRbpgSQod5xsQeGlAyIknK0nQfDeIzS5hIiyN07P0LIUQIyg_REaWcxTsboI8HWHZWBqjxdLN24L1pG9xqPO9WssEzY-Vy6UyD47kDJ4NpWrUN4PED-M4G3wuTbWj9K1gI0uJr4123DrHmEi9a7_uyCVj79f7ZDzyun8H_qLKpf5SYVxbw2MXvwyk60NJ6OPudJ-hpNn2czJPF_c3tZLxIVFbkIRnlBZVaw4izlBVaVnnFlRCc6CyvMq1HnFSS1zSaC5ICy4qKEcYkCJKloubZCRruepWLSzrQ5dqZlXTbkpKyR1v2aMsebdmjjYGLXWDdVSuo_-y_LKNB7AwQ134z4EqvDDQKauNAhbJuzX_d35H4iq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</creator><creatorcontrib>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</creatorcontrib><description>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</description><identifier>ISSN: 0014-4827</identifier><identifier>EISSN: 1090-2422</identifier><identifier>DOI: 10.1006/excr.2001.5348</identifier><identifier>PMID: 11640884</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adherens Junctions - metabolism ; Animals ; Anti-Bacterial Agents - pharmacology ; apoptosis ; Apoptosis - physiology ; Cadherins - metabolism ; Cell Adhesion - physiology ; cell cycle ; Cell Division - physiology ; Cell Line ; Cell Size - physiology ; Cytoskeletal Proteins - metabolism ; cytoskeleton ; Cytoskeleton - physiology ; Cytoskeleton - ultrastructure ; Desmogleins ; Desmoplakins ; Desmosomes - metabolism ; Epidermis - cytology ; filaggrin ; gamma Catenin ; Gene Expression - drug effects ; Gene Expression - physiology ; Humans ; In Vitro Techniques ; Intermediate Filament Proteins - analysis ; Intermediate Filament Proteins - genetics ; Intermediate Filament Proteins - metabolism ; Intermediate Filaments - metabolism ; keratinocyte ; Keratinocytes - chemistry ; Keratinocytes - cytology ; Keratinocytes - physiology ; Keratins - metabolism ; Microscopy, Immunoelectron ; Rats ; Tetracycline - pharmacology ; Vimentin - genetics ; Vimentin - metabolism</subject><ispartof>Experimental cell research, 2001-11, Vol.270 (2), p.199-213</ispartof><rights>2001 Academic Press</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</citedby><cites>FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/excr.2001.5348$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11640884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Presland, Richard B.</creatorcontrib><creatorcontrib>Kuechle, Melanie K.</creatorcontrib><creatorcontrib>Lewis, S.Patrick</creatorcontrib><creatorcontrib>Fleckman, Philip</creatorcontrib><creatorcontrib>Dale, Beverly A.</creatorcontrib><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><title>Experimental cell research</title><addtitle>Exp Cell Res</addtitle><description>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</description><subject>Adherens Junctions - metabolism</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Cadherins - metabolism</subject><subject>Cell Adhesion - physiology</subject><subject>cell cycle</subject><subject>Cell Division - physiology</subject><subject>Cell Line</subject><subject>Cell Size - physiology</subject><subject>Cytoskeletal Proteins - metabolism</subject><subject>cytoskeleton</subject><subject>Cytoskeleton - physiology</subject><subject>Cytoskeleton - ultrastructure</subject><subject>Desmogleins</subject><subject>Desmoplakins</subject><subject>Desmosomes - metabolism</subject><subject>Epidermis - cytology</subject><subject>filaggrin</subject><subject>gamma Catenin</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - physiology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Intermediate Filament Proteins - analysis</subject><subject>Intermediate Filament Proteins - genetics</subject><subject>Intermediate Filament Proteins - metabolism</subject><subject>Intermediate Filaments - metabolism</subject><subject>keratinocyte</subject><subject>Keratinocytes - chemistry</subject><subject>Keratinocytes - cytology</subject><subject>Keratinocytes - physiology</subject><subject>Keratins - metabolism</subject><subject>Microscopy, Immunoelectron</subject><subject>Rats</subject><subject>Tetracycline - pharmacology</subject><subject>Vimentin - genetics</subject><subject>Vimentin - metabolism</subject><issn>0014-4827</issn><issn>1090-2422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kN1KwzAUx4MoOj9uvZQ8gJ1Jm6bZ5ZibEweC6HVJ05MZzdqRpLLd-QiCb-iTmDrBKyFwQv4fOfwQOqdkSAnhV7BRbpgSQod5xsQeGlAyIknK0nQfDeIzS5hIiyN07P0LIUQIyg_REaWcxTsboI8HWHZWBqjxdLN24L1pG9xqPO9WssEzY-Vy6UyD47kDJ4NpWrUN4PED-M4G3wuTbWj9K1gI0uJr4123DrHmEi9a7_uyCVj79f7ZDzyun8H_qLKpf5SYVxbw2MXvwyk60NJ6OPudJ-hpNn2czJPF_c3tZLxIVFbkIRnlBZVaw4izlBVaVnnFlRCc6CyvMq1HnFSS1zSaC5ICy4qKEcYkCJKloubZCRruepWLSzrQ5dqZlXTbkpKyR1v2aMsebdmjjYGLXWDdVSuo_-y_LKNB7AwQ134z4EqvDDQKauNAhbJuzX_d35H4iq0</recordid><startdate>20011101</startdate><enddate>20011101</enddate><creator>Presland, Richard B.</creator><creator>Kuechle, Melanie K.</creator><creator>Lewis, S.Patrick</creator><creator>Fleckman, Philip</creator><creator>Dale, Beverly A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20011101</creationdate><title>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</title><author>Presland, Richard B. ; Kuechle, Melanie K. ; Lewis, S.Patrick ; Fleckman, Philip ; Dale, Beverly A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-9571affe964247fab5b6c8860f35b3ff960ba6d1375702e437b4044ae80328d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adherens Junctions - metabolism</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Cadherins - metabolism</topic><topic>Cell Adhesion - physiology</topic><topic>cell cycle</topic><topic>Cell Division - physiology</topic><topic>Cell Line</topic><topic>Cell Size - physiology</topic><topic>Cytoskeletal Proteins - metabolism</topic><topic>cytoskeleton</topic><topic>Cytoskeleton - physiology</topic><topic>Cytoskeleton - ultrastructure</topic><topic>Desmogleins</topic><topic>Desmoplakins</topic><topic>Desmosomes - metabolism</topic><topic>Epidermis - cytology</topic><topic>filaggrin</topic><topic>gamma Catenin</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - physiology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Intermediate Filament Proteins - analysis</topic><topic>Intermediate Filament Proteins - genetics</topic><topic>Intermediate Filament Proteins - metabolism</topic><topic>Intermediate Filaments - metabolism</topic><topic>keratinocyte</topic><topic>Keratinocytes - chemistry</topic><topic>Keratinocytes - cytology</topic><topic>Keratinocytes - physiology</topic><topic>Keratins - metabolism</topic><topic>Microscopy, Immunoelectron</topic><topic>Rats</topic><topic>Tetracycline - pharmacology</topic><topic>Vimentin - genetics</topic><topic>Vimentin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Presland, Richard B.</creatorcontrib><creatorcontrib>Kuechle, Melanie K.</creatorcontrib><creatorcontrib>Lewis, S.Patrick</creatorcontrib><creatorcontrib>Fleckman, Philip</creatorcontrib><creatorcontrib>Dale, Beverly A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Experimental cell research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Presland, Richard B.</au><au>Kuechle, Melanie K.</au><au>Lewis, S.Patrick</au><au>Fleckman, Philip</au><au>Dale, Beverly A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest</atitle><jtitle>Experimental cell research</jtitle><addtitle>Exp Cell Res</addtitle><date>2001-11-01</date><risdate>2001</risdate><volume>270</volume><issue>2</issue><spage>199</spage><epage>213</epage><pages>199-213</pages><issn>0014-4827</issn><eissn>1090-2422</eissn><abstract>Filaggrin is an intermediate filament (IF)-associated protein that aggregates keratin IFs in vitro and is thought to perform a similar function during the terminal differentiation of epidermal keratinocytes. To further explore the role of filaggrin in the cytoskeletal rearrangement that accompanies epidermal differentiation, we generated keratinocyte cell lines that express human filaggrin using a tetracycline-inducible promoter system. Filaggrin expression resulted in reduced keratinocyte proliferation and caused an alteration in cell cycle distribution consistent with a post-G1 phase arrest. Keratin filament distribution was disrupted in filaggrin-expressing lines, while the organization of actin microfilaments and microtubules was more mildly affected. Evidence for direct interaction of filaggrin and keratin IFs was seen by overlay assays of GFP–filaggrin with keratin proteins in vitro and by filamentous filaggrin distribution in cells with low levels of expression. Cells expressing moderate to high levels of filaggrin showed a rounded cell morphology, loss of cell–cell adhesion, and compacted cytoplasm. There was also partial or complete loss of the desmosomal proteins desmoplakin, plakoglobin, and desmogleins from cell–cell borders, while the distribution of the adherens junction protein E-cadherin was not affected. No alterations in keratin cytoskeleton, desmosomal protein distribution, or cell shape were observed in control cell lines expressing β-galactosidase. Filaggrin altered the cell shape and disrupted the actin filament distribution in IF-deficient SW13 cells, demonstrating that filaggrin can affect cell morphology independent of the presence of a cytoplasmic IF network. These studies demonstrate that filaggrin, in addition to its known effects on IF organization, can affect the distribution of other cytoskeletal elements including actin microfilaments, which can occur in the absence of a cytoplasmic IF network. Further, filaggrin can disrupt the distribution of desmosome proteins, suggesting an additional role(s) for this protein in the cytoskeletal and desmosomal reorganization that occurs at the granular to cornified cell transition during terminal differentiation of epidermal keratinocytes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11640884</pmid><doi>10.1006/excr.2001.5348</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4827
ispartof Experimental cell research, 2001-11, Vol.270 (2), p.199-213
issn 0014-4827
1090-2422
language eng
recordid cdi_crossref_primary_10_1006_excr_2001_5348
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adherens Junctions - metabolism
Animals
Anti-Bacterial Agents - pharmacology
apoptosis
Apoptosis - physiology
Cadherins - metabolism
Cell Adhesion - physiology
cell cycle
Cell Division - physiology
Cell Line
Cell Size - physiology
Cytoskeletal Proteins - metabolism
cytoskeleton
Cytoskeleton - physiology
Cytoskeleton - ultrastructure
Desmogleins
Desmoplakins
Desmosomes - metabolism
Epidermis - cytology
filaggrin
gamma Catenin
Gene Expression - drug effects
Gene Expression - physiology
Humans
In Vitro Techniques
Intermediate Filament Proteins - analysis
Intermediate Filament Proteins - genetics
Intermediate Filament Proteins - metabolism
Intermediate Filaments - metabolism
keratinocyte
Keratinocytes - chemistry
Keratinocytes - cytology
Keratinocytes - physiology
Keratins - metabolism
Microscopy, Immunoelectron
Rats
Tetracycline - pharmacology
Vimentin - genetics
Vimentin - metabolism
title Regulated Expression of Human Filaggrin in Keratinocytes Results in Cytoskeletal Disruption, Loss of Cell–Cell Adhesion, and Cell Cycle Arrest
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T11%3A53%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulated%20Expression%20of%20Human%20Filaggrin%20in%20Keratinocytes%20Results%20in%20Cytoskeletal%20Disruption,%20Loss%20of%20Cell%E2%80%93Cell%20Adhesion,%20and%20Cell%20Cycle%20Arrest&rft.jtitle=Experimental%20cell%20research&rft.au=Presland,%20Richard%20B.&rft.date=2001-11-01&rft.volume=270&rft.issue=2&rft.spage=199&rft.epage=213&rft.pages=199-213&rft.issn=0014-4827&rft.eissn=1090-2422&rft_id=info:doi/10.1006/excr.2001.5348&rft_dat=%3Cpubmed_cross%3E11640884%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11640884&rft_els_id=S0014482701953480&rfr_iscdi=true